Advertisement

Topics

CytRx Reports Third Quarter 2017 Financial Results

09:00 EST 8 Nov 2017 | BioMedReports - Blog

"The third quarter of 2017 was transformative for CytRx," said Steven A. Kriegsman, CytRx's Chairman and CEO. "We executed a global strategic licensing transaction

Read more...

Original Article: CytRx Reports Third Quarter 2017 Financial Results

NEXT ARTICLE

More From BioPortfolio on "CytRx Reports Third Quarter 2017 Financial Results"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...